Columbia Partners Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Columbia Partners Investment Management's GILD Position: Q2 2018 in Review
Columbia Partners Investment Management sold out of Gilead Sciences (GILD) in Q2 2018, closing a stake of 29,826 shares — an estimated $2.25M sold.
Columbia Partners Investment Management first reported a position in GILD in Q2 2013 and held it in 15 quarters. The position peaked at $14.3M in Q1 2014. 1,523 funds tracked by Wall St. Rank hold GILD as of Q2 2018.
- Columbia Partners Investment Management reported no remaining Gilead Sciences position as of Q2 2018 after selling out during the quarter.
- Columbia Partners Investment Management sold 29,826 Gilead Sciences shares in Q2 2018, an estimated $2.25M.
- Columbia Partners Investment Management first reported a position in Gilead Sciences in Q2 2013 and held it in 15 quarters.
- Columbia Partners Investment Management's Gilead Sciences position peaked at $14.3M in Q1 2014.
- 1,523 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2018.
Based on Columbia Partners Investment Management's 13F filing for Q2 2018, filed 12 Jul 2018.